This little bracelet helps you fall asleep faster and longer

For starters, there are no miraculous claims of immediately better sleep, and what it does promise is reasonable. For example, Apollo Neuroscience, the company behind the wearable, says you need to use the bracelet at least five days a week, for three hours a day, to see optimal benefits. And what are those benefits? According to research, consistent use of the Apollo wearable left users with an extra 30 minutes of sleep at night, a 14% increase in REM sleep, and a 19% increase in deep sleep, all of which are reasonable claims to make and great if you need that extra little push for better sleep. But how does it work?

Well, primarily, the Apollo wearable uses silent touch therapy to interfere with stress that the body builds up. Think of it as a mini-massage for your nervous system, and you can wear the device anywhere for it to work. Whether it’s on your wrist like a watch or your ankle, you still receive the positive effects of the vibrations, which is convenient for those of us who already wear a watch or bracelets. The wearable pairs with an app that allows you to pick from different goal-based modes — like Unwind, Focus, and Fall Asleep — intensities and integrate into other health trackers, such as the Oura ring.

Since Apollo combats our natural stress responses, it’s a great product to use beyond getting better sleep. Imagine what you can do if you generally feel less stressed? The wearable can help you be calmer overall, help with things like meditation and mindfulness, and even help you focus on your work rather than the stress you’re having. It can even help us recover from stress quicker in the long term by improving our heart rate variability (HRV), a biomarker for how well our bodies recover and respond to daily pressures.

Right off the bat, we’ll let you know that the Apollo wearable has gone through several clinical trials and real-world studies, and they take their research seriously. While the sample sizes of the studies may appear small at first glance, some of the studies are double-blind randomized placebo-controlled crossovers trials, which are the gold standard in scientific methodology. It also increases the legitimacy of the research. Apollo Neuro has completed seven clinical trials, and even better, the parent company is conducting nine new clinical trials with significantly larger sample sizes, the biggest one being 6,000 participants, which is a good sign since companies, universities, and medical organizations will not put a ton of money into research and studies if there isn’t some merit.